[Penicillamine in the light of current clinical research].
D000931:Antidotes; D001168:Arthritis / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002908:Chronic Disease; D003094:Collagen / Q000037:antagonists & inhibitors; D003300:Copper / Q000506:poisoning; D003864:Depression, Chemical; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007855:Lead Poisoning / Q000188:drug therapy; D008259:Macroglobulins / Q000037:antagonists & inhibitors; D008630:Mercury Poisoning / Q000188:drug therapy; D009532:Nickel / Q000506:poisoning; D010396:Penicillamine / Q000494:pharmacology / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000931:Antidotes; D008259:Macroglobulins; D003300:Copper; D009532:Nickel; D003094:Collagen; D010396:Penicillamine
Penicilamin u svjetlu najnovijih klinickih istrăzivanja.